| 000 | 01812 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513090858.0 | ||
| 264 | 0 | _c19960705 | |
| 008 | 199607s 0 0 eng d | ||
| 022 | _a0340-7004 | ||
| 024 | 7 |
_a10.1007/BF01526556 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGorelik, L | |
| 245 | 0 | 0 |
_aLow-dose-melphalan-induced up-regulation of type-1 cytokine expression in the s.c. tumor nodule of MOPC-315 tumor bearers and the role of interferon gamma in the therapeutic outcome. _h[electronic resource] |
| 260 |
_bCancer immunology, immunotherapy : CII _cDec 1995 |
||
| 300 |
_a363-74 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xadministration & dosage |
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 |
_aCytotoxicity, Immunologic _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 |
_aInterferon-gamma _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aMelphalan _xadministration & dosage |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 | _aNeoplasm Transplantation |
| 650 | 0 | 4 |
_aPlasmacytoma _ximmunology |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 |
_aRNA, Messenger _xbiosynthesis |
| 650 | 0 | 4 | _aStimulation, Chemical |
| 650 | 0 | 4 |
_aT-Lymphocytes, Cytotoxic _xdrug effects |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xbiosynthesis |
| 700 | 1 | _aMokyr, M B | |
| 773 | 0 |
_tCancer immunology, immunotherapy : CII _gvol. 41 _gno. 6 _gp. 363-74 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF01526556 _zAvailable from publisher's website |
| 999 |
_c8634233 _d8634233 |
||